Expanded clinical target volume and survival in non-operative ESCC: Prognostic benefits and inflammatory risks
Advances in Clinical and Experimental Medicine · 2026
DOI: 10.17219/acem/203882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2026. Verfasst von Dizhi Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Qilu Hospital of Shandong University, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Department of Medical Imaging, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Zitieren
APA
Jiang, D., Huang, C., Guo, K., Zhang, X., Ma, X., Mao, H., Li, Z., Cheng, W., & Cheng, Y. (2026). Expanded clinical target volume and survival in non-operative ESCC: Prognostic benefits and inflammatory risks. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/203882
Vancouver
Jiang D, Huang C, Guo K, Zhang X, Ma X, Mao H, et al. Expanded clinical target volume and survival in non-operative ESCC: Prognostic benefits and inflammatory risks. Advances in Clinical and Experimental Medicine. 2026. doi:10.17219/acem/203882
BibTeX
@article{Jiang2026,
author = {Jiang, Dizhi and Huang, Chenhan and Guo, Kaiyue and Zhang, Xinyu and Ma, Xinyue and Mao, Hongyuan and Li, Zerun and Cheng, Wenhao and Cheng, Yufeng},
title = {Expanded clinical target volume and survival in non-operative ESCC: Prognostic benefits and inflammatory risks},
journal = {Advances in Clinical and Experimental Medicine},
year = {2026},
doi = {10.17219/acem/203882}
}
EUVIMED